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Neoplasm antigens outnumber the enzymes which are utilized to determine the cancer. Cancer 
development in the living organisms chronologically follows the cytotoxic, organotoxic and mutagenic 
alterations. Generally, the first symptom for chemical carcinogens is a metabolical response in 
connection with the detoxification phenomenon and for the infective agents the first symptom is often 
an immune response. Many nitrosamines similar to N-nitrosomorpholine have been considered as 
carcinogens. The cancerogenic effect of N-nitrosomorpholine (NMOR) on different animal species has 
been confirmed experimentally. The aim was to analyse the acute toxic effect of the N-
nitrosomorpholine on the Rattus norvegicus race rats in this study. The administration of N-
nitrosomorpholine causes alteration of some enzymes. The enzyme activities of alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate 
dehydrogenase (LDH) were determined for all the samples of blood serum and liver tissue. The results 
demonstrated that there was an increase in the levels of the ALP, ALT, AST and LDH enzyme activities 
regarding to the in vivo effect of the N-nitrosomorpholine and the increases were evaluated as the 
metabolic response of liver to hepatotoxic action. NMOR results in the modifications on the biological 
macromolecules owing to its alkylating characteristic. The degradation and turn over of the protein 
gains speed gradually till alkylating factor disappear. This case in the circulation appears as the 
increase of the enzyme activity. These alterations are responsible for carcinogenicity and happen as 
liver cancer observation in the liver.  
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N-Nitrosomorpholine (NMOR) belongs to the group of N-
nitrosamines and represents a known hepatocarcinogen. 
N-nitrosomorpholine (NMOR) produces in toxic and 
tumoric phenomenon different animal species. The different 
types of injections with NMOR such as intravenous, intra-
abdominal or gastrointestinal injection does not alter the 
result and when the tumoric phenomenon like first 
metabolic alterations happen, hepatocellular carcinoma 
(HCC) are primarily seen on the liver (IARC, 1982; Jarman 
and Mason, 1986; Vermeer et al., 2004; Slamenova et 
al., 2008). 
Heterocyclic N-nitrosomorpholine is an endogenously 
formed N-nitroso compound. Nitrates and amine mor-
pholines, its precursors, are found in many common 
foods and can react in peptic ulcer (Newsholm and 
Leech, 1986; Tietz, 1987; Leaf et al., 1991).  
The toxic effects of NMOR were examined on various 
types of animal models and LD50 doses were detected. 
Lower doses (40-80ppm) of NMOR have been observed 
to raise the survival rate of the hepatocytes. Survival 
rates in the 80 ppm group and in the 40 ppm group were 
57 and 81%, respectively, and these values were signify-
cantly higher than that in 120 ppm. Its high concen-
trations such as 10.2 mM led to increase in the number of 
necrotic cells pointing out to cytotoxicity. For this reason, 
carcinogenic effect was proven occur when morpholine 
and NaNO2 which were the precursors of NMOR were 
given together through the planned controlled experiment 
systems and in this way the morpholine may be nitro-
zoned in vivo conditions (Reddy and Mori 1981; Mayer et 
al., 1983; Yoshino et al., 2005). 
NMOR metabolized by  rat  liver  microsome  system  is  
 




composed of acetaldehyde, formaldehyde, glyoxal and N-
nitroso-2-hydroxymorpholine (Apel, 1980; ShengXue et 
al., 2008). Hecht and Young (1981) isolated the -hydro-
xylation and 2-hydroxyl-1,4-dioxan. This aldehyde is 
interesting due to being a derivative of the dioxin as 
hepatocarcinogen. The NMOR was considered to be the 
responsible of the destructive effect on the cell structures 
(Hecht and Young 1981; Atalay, 1981). Necrosis and 
tumour in livers and pancreas were observed in the cats 
and dogs which were treated with glioxan. 
In previous studies, carcinogenic effect of NMOR was 
obtained after the interaction with DNA. NMOR was 
observed to induce DNA damage as dependent on the 
concentration in the hepatocyte cultures of human and 
rat. NMOR results in site-specific hypometilation of the c -
myconcogene in the nodules of the liver. Genotoxic lesion 
induced by NMOR is inherited to the coming generations 
(Gmez et al., 1974; Robichova and Slamenova, 2001; 
Lazarova et al., 2006). The antioxidants such as Vitamins 
C and E were considered to inhibit mutagenicity by 
promoting the repair of DNA damage induced by N -
nitroso compounds (Robichova and Slamenova, 2001). 
Since the recognition of the cancer still requires histo-
pathological findings, in vivo experiments are generally 
monitored on a morphological basis. The acute hepatoxic 
effect of the NMOR on rats was assesed. The activity 
changes of the enzymes such as aspartate amino-
transferase (AST), alanine aminotransferase (ALT), alkaline 
phosphatase (ALP) and lactate dehydrogenase (LDH) in 
the blood serums and liver tissue extracts was evaluated 
as a result of this effect in this study.  
 
 
MATERIALS AND METHODS 
 
The preparation of the rats 
 
Rattus hovegicus and 70 different rats were taken to two big cages 
according to their genders. 5 distinct experimental groups were 
formed by picking 4 rats randomly from each cage. Five animals 
from opposite gender that will be utilized with each group as control 
were taken to a different cage. They were fed with pellet forage 





Two males and females have been separated from the rats 
allocated to the preliminary studies. The rats which were left to 
starve were weighted in the practice. 1 µl physiological serum for 
each of 100 g of their body weights was injected to the control 
group. The blood was drawn from the heart of one of them every 
day at the same hour after the injection. The liver was perfused by 
opening of the abdomen after the ether anesthesia. The enzyme 
activities of the ALP, AST, ALT and LDH of the blood sample and 
liver tissue homogenates were measured spectrophotometrically. 
Different doses of NMOR were administered to the other rats and 
enzyme activities were measured as from the sixth hour.  
 
 
Experimental groups  
 





kg body weight, it was dissolved to 1.6 mg/ ml. The rats which were 
left to starve for 24 h were weighted during the practice and they 
were injected into blood vessel 1 µl NMOR solution for each of 100 
g of their body weights as well as the same-volume- physiological 
serum were injected to the control group. Measurements were 
individually carried out through the auto-analyser RA- 1000 on the 
male and female rats of the 6, 12, 18, 24 and 30 -time point-groups. 
The heart blood drawn from the experimental and control animals 
which were fainted by ether after the fixed in vivo time periods was 
left to coagulate. The serums were obtained through centrifugation 
for 5 min at 3000 rpm after the coagulation. The liver tissue of the 
related rats were extracted through physiological serum following 
the drawing after their being perfused. The tissue samples which 
weigh approximately 1 g were homogenized by physiological serum 
at the nine times more volume than their body weights. These 
homogenates were centrifuged for 20 min at 25000 g and the 
measurements of enzyme activity were carried out at the super-





The transformation of the NADH+H into NAD+ during the enzyme 
activity of the Alanine Amino Transferase in the blood serum 
samples and the liver tissue extracts were measured at 340 nm 
wavelength. NADH+H oxidation at the enzyme reaction of the 
Aspartate Amino Transferase (AST) was measured at 340 nm. P-
nitrophenol produced at the reaction of Alanine Phosphatase (ALP) 
in the samples was measured 405 nm and the results of the activity 
were calculated according to the unit/ litre (u/ l) that is the 





Statistical analysis of the difference between ALP, AST, ALT and 
LDH levels of the control and groups with NMOR treatment was 
carried out using analysis of variance (ANOVA) and t test at the 
programme of SPSS 13 version. The results were given as average 
± standard deviation. P < 0.05, the difference between two groups, 





ALP, AST, ALT and ALT enzyme activity values of the 
blood serum and liver extract of the experimental and 
control rats were shown in Tables 1, 2, 3 and 4 according 
to the effect time period of NMOR.  
There were statistically significant alterations (p < 0.05) 
on the ALP enzyme level in the blood serum and liver 
extract between groups with NMOR treatment and control 
groups at the 6th, 12th, 18th, 24th and 30th h (Figures 1 and 
2). There was a significant increase in the ALP enzyme 
activity in the liver as at the 12th h (Table 1).  
The AST enzyme activity level went up in the blood 
serum as at the 6th h although it declined in the liver 
(Figures 3 and 4).  
A significant increase in the ALT enzyme activity was 
seen in the blood serum in comparison to the control 
group (Table 3). It was observed that the average activity 
declined in the liver extract compared to the control group 
(Figures 5 and 6).  
It was seen that LDH  enzyme  activities  had  suddenly  
 














X (blood serum) P = 0.02 X (liver tissue) P = 0.006 
Male Female Male Female 
6th hour 271 ± 22 239 ± 24 75 ± 6.57 105 ± 9.12 
12th hour 318 ± 12 289 ± 18 83 ± 9.48 110 ± 11.03 
18th hour 338 ± 12 312 ± 15 101 ± 9.03 119 ± 11.35 
24th hour 362 ± 10 293 ± 13 135 ± 19.13 149 ± 20.54 
30th hour 350 ± 15 252 ± 49 157 ± 10.51 167 ± 9.73 
Control groups  
6th hour  175 ± 19 112 ± 12 79 ± 7 128 ± 12 
12th hour  159 ± 18 196 ± 14 88 ± 10 102 ± 9 
18th hour  281 ± 25 232 ± 15 77 ± 5 95 ± 10 
24th hour 310 ± 9 195 ± 11 107 ± 9 125 ± 11 














X (blood serum) P = 0.02 X (liver tissue) P = 0.05 
Male Female Male Female 
6th h 80 ± 9 125 ± 14 357 ± 7.28 369 ± 10 
12th h 97 ± 10 155 ± 16 363 ± 15.1 359 ± 8 
18th h 124 ± 28 178 ± 79 330 ± 22.75 354 ± 6 
24th h 169 ± 11 191 ± 23 310 ± 18 343 ± 21 
30th h 195 ± 24 199 ± 12 288 ± 11.87 339 ± 12 
Control groups  
6th h 59 ± 6 131 ± 27 351 ± 28 458 ± 19 
12th h 78 ± 8 98 ± 11 357 ± 18 418 ± 14 
18th h 112 ± 17 65 ± 8 380 ± 18 332 ± 9 
24th h 67 ± 7 134 ± 13 409 ± 24 427 ± 15 














X (blood serum) P = 0.004 X (liver tissue) P = 0.001 
Male Female Male Female 
6th hour 191 ± 13 225 ± 25 387 ± 9.35 357 ± 6 
12th hour 206 ± 7.5 246 ± 31 380 ± 23.51 351 ± 18 
18th hour 227 ± 31 282 ± 39 390 ± 16.69 356 ± 15 
24th hour 306 ± 6.3 352 ± 22 398 ± 16.28 361 ± 11 
30th hour 375 ± 9 391 ± 31 404 ± 21.13 370 ± 22 
Control groups  
6th hour 158 ± 8 174 ± 6 399 ± 18 402 ± 21 
12th hour 117 ± 5 187 ± 4 391 ± 17 371 ± 22 
18th hour 303 ± 14 176 ± 7 385 ± 14 363 ± 10 
24th hour 154 ± 11 259 ± 26 423 ± 26 397 ± 24 
30th hour 183 ± 7 260 ± 25 457 ± 28 352 ± 18 
 














X (blood serum) P = 0.05 X (liver tissue) P = 0.09 
Male Female Male Female 
6th hour 699 ± 52 764 ± 123 1590 ± 70.32 1591 ± 68 
12th hour 1038 ± 85 964 ± 128 1503 ± 76.02 1529 ± 64 
18th hour 1057 ± 94 950 ± 167 1460 ± 47.9 1495 ± 52 
24th hour 1028 ± 90 928 ± 265 1413 ± 71.1 1505 ± 81 
30th hour 989 ± 126 909 ± 133 1437 ± 71 1453 ± 42 
Control groups  
6th hour 587 ± 43 837 ± 69 1719 ± 67 1792 ± 74 
12th hour 653 ± 58 613 ± 51 1744 ± 54 1703 ± 50 
18th hour 689 ± 69 567 ± 24 1721 ± 32 1661 ± 38 
24th hour 720 ± 99 696 ± 50 1606 ± 21 1768 ± 65 
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Figure 1. ALP enzyme activities observed in the blood serums and liver extracts of the 




increased after the NMOR treatment on the rats (Table 4; 
Figures 7 and 8).  
The data on the tables showed that all the enzyme 
activity values of the male and female rats had increased 
due to the hepatotoxic effect of NMOR compared to the 
control group.  
The alkylation of the enzyme proteins with NMOR 
injections causes directly alteration of enzyme activities. 
That this alteration had appeared within a short time 
period was a drastic proof of the active sensibility shown 
by the target cells against the cytotoxic effect of NMOR  





N-Nitrosomorpholine (NMOR), the in vivo effect of which 
was assesed on ALP, ALT, AST and LDH enzyme activity 
in R. norvegicus blood serums and liver homogenates, is 
a cyclic nitrosamine. 
Nitrosamines have toxic effect especially on the mammals 
and microorganisms (Lijinsky and Taylor, 1975; Swann  
 




Blood serum Liver extract  
 
Figure 2. ALP enzyme activities observed in the blood serums and liver extracts of the 
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Figure 3. AST enzyme activities observed in the blood serums and liver extracts of the 




and Magee, 1986). NMOR was reported to attach to the 
liver DNAs of the rats with very low doses. The in vivo 
genotoxicity studies have demostrated that it results in 
induction of uncontrolled DNA synthesis, and formation of 
hepatocytes with micronuclei, in the liver (Robichova et 
al., 2004).  
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Figure 4. AST enzyme activities observed in the blood serums and liver extracts of the 
female rats of the 6, 12, 18, 24 and 30-hour-experimental groups. 
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Figure 5. ALT enzyme activities observed in the liver extracts and weights of the female 




Cytotoxicity of NMOR was evaluated by Caco-2 cells. 
NMOR caused very slight dose-dependent inhibition of 
DNA synthesis in Caco-2 cells. The higher concentrations 
of NMOR (1.7 mmol) stimulated DNA synthesis (Robichova 
and Slamenova, 2002). Alkylating characteristic of the 
NMOR leading to modifications on the biological macro-
molecules was the main factor of determining the results 
of this study. The proteins undergo a structural modification  
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Figure 6. ALT enzyme activities observed in the blood serums and liver extracts of 
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Figure 7. LDH enzyme activities observed in the blood serums and liver extracts of 




in cellular compartments before joining to serum or 
circulation (Yoshino et al., 2005). Therefore the enzyme 
activities were expected to decline in this study. Although 
a modification appearing at the far point of the active 
centre of a protein with an enzymatic function is always 
considered to result in activity losses, it is unlikely to 
further activate the protein regarding its natural and 
functional structure. NMOR and the other nitrosamines 
are known to have in vitro inhibition effects over these 
enzymes    (Atalay,   1981;  Zubay, 1983).   Whether   the  
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Figure 8. LDH enzyme activities observed in the blood serums and liver extracts of the 




catalytic loss of the molecule appears as alkylation in the 
active centre area or as a modification giving rise to 
stereochemical alteration, it is a specifically activity loss 
and it does not reflect on the activity only if the velocity of 
the synthesis increases. A modified protein is destroyed 
by the living system. This destruction induces the 
metabolic control ways thus raises the velocity of the 
protein synthesis (Zubay, 1983). So long as the 
probability of the alkylation increases during the accele-
rating synthesis, the degradation and turn over of the 
protein gains speed gradually till alkylating factor 
disappear. As the extracellular proteins free themselves 
from cellular destruction, this case in the circulation 
appears as the increase of the enzyme activity. The cell 
membrane may lose the differential permeability through 
the alkylation of the macromolecules in its structure 
(Newsholm and Leech, 1986). This modification brings 
about proteins in the cytoplasm leaking to the 
extracellular matrix thus the enzymes accelerating their 
turn over appear in the extracellular matrix. This case 
forces the mitochondrial enzymes to leak to the cyto-
plasm and then to the extracellular matrix thus increases 
the AST activity (Table 2). According to Ozcan and Mengi 
(1998), transaminases (also called aminotransferases) 
are released into circulation from their compartment (the 
liver) when there is damage to hepatocytes and this leads 
to increase in their activities in the blood. The increase in 
the serum AST at the 18th hour stems from the fact that 
AST is a mitochondrial enzyme, whereas ALT is a cyto-
plasmic enzyme. Early start of the serum ALP at the 6th h 
was assesed as it is the membrane enzyme (Table 1). 
The sudden and linear increase of the LDH is only found 
in cytoplasm (Table 4). Their concentrations may alter 
fast depending on the modifications whose half-life is 
short like some biomolecules having a regulatory duty on 
the metabolic pathways and affecting the speed of the 
synthesis or destruction of the proteins whose turn-over 
is rapid. The alteration results in changing rapidly the 
enzyme concentrations regulating the metabolic pathway 
in a certain way. The circle speed of functional protein 
molecules provides the control, the regulation or the 
sensibility of the detoxification function like the liver 
(Newsholm and Leech, 1986; Özcan and Mengi, 1998; 
Loeppky et al., 2005).   
Many animal models have been developed to elucidate 
the mechanism underlying metastasis (Yoshino et al., 
2005). Although the tumoral development or mutagenic 
changes could begin in a short time period, this can only 
make fast scanning of chemical cancerogenic easier; it is 
not enough for cancer recognition. The most effective 
tools which would be useful in early recognition might be 
the biomolecules in circulation or other body fluids.  
This study demostrated that N-nitrosomorpholine 
(NMOR) has toxic effect on enzyme activity levels. 
NMOR results in the modifications on the biological 
macromolecules like protein and nucleic acid owing to its 
alkylating characteristic. Hence, it is quite normal for it to 
rapidly alter the functions of the liver. The rat model 
presented here provides a good tool for the assessment 






formation and for analysis of the individual steps in the 





Apel KE, Schrenk D, Schwarz M, Mahr B, Kunz W (1980). Denitrosation 
of NMOR by liver microsomes; possible role of Cytochrome p. 450. 
Can. Lett. 9: 13-20. 
Atalay A (1981). Nitrosolu bileiklerin sıçan karacier Laktat 
Dehidrongenaz enzimine in vitro etkileri. C. Ü. Tıp Fak. Derg. 3: 208-
214. 
Gmez RF, Johnstoon M, Snskey AJ (1974). Activation of 
nitrosomorpholine and nitrosopyrolidine to bacterial mutagens. Mutat. 
Res. 24: 5-7. 
Hecht SS, Young R (1981). Metabolic-hydroxilation of NMOR and 
3,3,5,5-tetradeutera-N-Nitrosomorpholine in the F 344 Rat. Can. Res. 
41: 5039-5043. 
IARC (1982). Monographson the evaluation of the carcinogenic risk to 
humans. Rubber Ind. 28(23-30): 89-116. Lyon, IARC. 
Jarman M, Mason D (1986). The metabolism of N-Nitrosomorpholine by 
rat liver microsomes and its oxidation by the Fenton System. 
Carcinogenesis. 7: 559-565. 
Lazarova M, Labaj J, Eckl P, Kogan G, Slamenova D (2006). Effects of 
Dietary intake of a fungal -D-Glucan Derivative on the level of DNA 
damage induced in primary rat hepatocytes by various carcinogens. 
Nutr. Cancer, 56(1): 113-122. 
Leaf CD, Wishnok JS, Tannenbaum SR (1991). Endogenous 
incorporation of nitric oxide from L-arginine into N-nitrosomorpholine 
sitmulated by Escherichia coli lipopolysaccharide in the rat. 
Carcinogenesis, 12(3): 537-539. 
Lijinsky W, Taylor HM (1975). Increased carcinogeity of 2,6-
dimethylnitrosomorphaline compared with nitrosomorpholine in rats. 
Cancer Res. 35: 2123-2125. 
Loeppky RN, Sukhtankar S, Gu F, Park M (2005). The carcinogenic 
significance of reactive intermediates derived from 3-acetoxy- and 5-
acetoxy-2-hydroxy-N-nitrosomorpholine. Chem. Res. Toxicol. 18(12): 
1955-1966. 
Mayer D, Malcolm A, Bannasch P (1983). Influence of Phenobarbital on 
Glycogen of rat liver prebarbital with N-Nitrosomorpholine. 
Carcinogenesis, 4(7): 931-933. 
Newsholm EA, Leech AR (1986). Biochemistry for the medical 
sciences. J. Wiley and Sons Co. s. 395. Chichester.  
Ozcan A, Mengi A (1998). Ratlarda oral olarak verilen alkolün serum, 
karacier ve bObrek GT, ALT ve AST aktiviteleri ile serum total 






























Pegg AE, Hui G (1978). Formation and subsequent removal of 06-
Methylguanine from deoxyribonucleic acid in rat liver and kidney after 
small dosesof dimethylnitrosamine. J. Biochem. 173: 739-748. 
Reddy BS, Mori H (1981). Effect of dietary bran and dehydrated citrus 
fiber on 3,2-Dimethyl-4-Aminobiphenyl-ınduced intestinal 
carcinogenesis in F 344 rats. Carcinogenesis, 2: 21-35. 
Robichova S, Slamenova D (2001). Study of N-Nitrosomorpholine-
induced DNA strand breaks in Caco-2 cells by the classical and 
Modified comet assey: Influence of Vitamine E and C. Nutr. Cancer, 
39(2): 267-272. 
Robichova S, Slamenova D (2002). Effects of vitamins C and E on 
cytotoxicity induced by N-Nitroso compounds, N-Nitrosomorpholine 
and N-nethyl-N-nitro-N-nitrosoguanidine in Caco-2 and V9 cell lines. 
Cancer Lett. 182(1): 11-18. 
Robichova S, Slamenova D, Gabelova A, Sedlak J, Jakubikova J 
(2004). An investigation of genotoxic effects of N-nitrosomorpholine 
in mammalian cells. Chemico-Biological Interactions. 148: 163-171. 
ShengXue X,  GeLiang X, WeiDong J,  ZhiHua W,  JianSheng L,  
JinLiang M, Yong Sheng G (2008). Establishment of metastatic 
hepatocellular carcinoma model induced by diethylnitrosamine and 
N-nitrosomorpholine. Chin. J. Digest. Surg. 7(1): 46-48. 
Slamenova D, Sramkova M, Chalupa I, Smigova J, Kogan G (2008). 
Reduction of genotoxic effects of N-nitrosomorpholine in human 
hepatoma cells and hamster lung cells by carboxymethyl chitin-
glucan. Neoplasma, 55(4): 280-285. 
Swann PF, Magee JAPN (1986). Nitrosamine-ınduced carcinogenesis. 
Biochem. J. 110: 39-47. 
Tietz NW (1987). Fundamentals of Clinical Chemistry. W. B. Seunders 
Co. s. pp. 371-380, 711. Phyladelphia. 
Vermeer ITM, Henderson LY, Moonen EJC, Engels LGJB, Dallinga JW, 
van Maanen JMS, Kleinjans JCS (2004). Neutrophil-mediated 
formation of carcinogenic N-nitroso compounds in an in vitro model 
for intestinal inflammation. Toxıcol. Lett. 154(3): 175-182.  
Yoshino H, Futakuchi M, Cho YM, Ogawa K, Takeshita F, Imai N, 
Tamano S, Shirai T (2005). Modification of an in vivo lung metastasis 
model of hepatocellular carcinoma by low dose n-nitrosomorpholine 
and diethylnitrosamine. Clınıcal and Experımental Metastasıs. 22(5): 
441-447.  
Zubay G (1983). Biochemistry. Addison Wesley Publishing Co. 156 
(587): 929-964. Massachusetts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
